nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Connective tissue disorder—Vincristine—colon cancer	0.00455	0.00455	CcSEcCtD
Perflutren—Haemoglobin—Irinotecan—colon cancer	0.00453	0.00453	CcSEcCtD
Perflutren—Rhinitis—Irinotecan—colon cancer	0.00452	0.00452	CcSEcCtD
Perflutren—Haemorrhage—Irinotecan—colon cancer	0.00451	0.00451	CcSEcCtD
Perflutren—Connective tissue disorder—Irinotecan—colon cancer	0.00443	0.00443	CcSEcCtD
Perflutren—Visual impairment—Irinotecan—colon cancer	0.00434	0.00434	CcSEcCtD
Perflutren—Haemoglobin—Fluorouracil—colon cancer	0.00434	0.00434	CcSEcCtD
Perflutren—Rhinitis—Fluorouracil—colon cancer	0.00433	0.00433	CcSEcCtD
Perflutren—Haemorrhage—Fluorouracil—colon cancer	0.00431	0.00431	CcSEcCtD
Perflutren—Cardiac disorder—Vincristine—colon cancer	0.00429	0.00429	CcSEcCtD
Perflutren—Hypoaesthesia—Fluorouracil—colon cancer	0.00429	0.00429	CcSEcCtD
Perflutren—Pharyngitis—Fluorouracil—colon cancer	0.00428	0.00428	CcSEcCtD
Perflutren—Face oedema—Capecitabine—colon cancer	0.00421	0.00421	CcSEcCtD
Perflutren—Angiopathy—Vincristine—colon cancer	0.0042	0.0042	CcSEcCtD
Perflutren—Cardiac disorder—Irinotecan—colon cancer	0.00418	0.00418	CcSEcCtD
Perflutren—Flushing—Irinotecan—colon cancer	0.00418	0.00418	CcSEcCtD
Perflutren—Mediastinal disorder—Vincristine—colon cancer	0.00417	0.00417	CcSEcCtD
Perflutren—Cardiac arrest—Capecitabine—colon cancer	0.00414	0.00414	CcSEcCtD
Perflutren—Angiopathy—Irinotecan—colon cancer	0.00409	0.00409	CcSEcCtD
Perflutren—Coma—Methotrexate—colon cancer	0.00408	0.00408	CcSEcCtD
Perflutren—Immune system disorder—Irinotecan—colon cancer	0.00407	0.00407	CcSEcCtD
Perflutren—Mediastinal disorder—Irinotecan—colon cancer	0.00406	0.00406	CcSEcCtD
Perflutren—Chills—Irinotecan—colon cancer	0.00404	0.00404	CcSEcCtD
Perflutren—Arrhythmia—Irinotecan—colon cancer	0.00402	0.00402	CcSEcCtD
Perflutren—Dry skin—Capecitabine—colon cancer	0.00399	0.00399	CcSEcCtD
Perflutren—Back pain—Vincristine—colon cancer	0.0039	0.0039	CcSEcCtD
Perflutren—Arrhythmia—Fluorouracil—colon cancer	0.00385	0.00385	CcSEcCtD
Perflutren—Lymphadenopathy—Methotrexate—colon cancer	0.0038	0.0038	CcSEcCtD
Perflutren—Back pain—Irinotecan—colon cancer	0.00379	0.00379	CcSEcCtD
Perflutren—Muscle spasms—Irinotecan—colon cancer	0.00377	0.00377	CcSEcCtD
Perflutren—Erythema—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Perflutren—Bronchospasm—Capecitabine—colon cancer	0.00371	0.00371	CcSEcCtD
Perflutren—Agitation—Vincristine—colon cancer	0.0037	0.0037	CcSEcCtD
Perflutren—Sweating increased—Capecitabine—colon cancer	0.00367	0.00367	CcSEcCtD
Perflutren—Ill-defined disorder—Irinotecan—colon cancer	0.00364	0.00364	CcSEcCtD
Perflutren—Vertigo—Vincristine—colon cancer	0.00362	0.00362	CcSEcCtD
Perflutren—Leukopenia—Vincristine—colon cancer	0.0036	0.0036	CcSEcCtD
Perflutren—Vision blurred—Fluorouracil—colon cancer	0.00354	0.00354	CcSEcCtD
Perflutren—Malaise—Irinotecan—colon cancer	0.00354	0.00354	CcSEcCtD
Perflutren—Vertigo—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Syncope—Irinotecan—colon cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Leukopenia—Irinotecan—colon cancer	0.00351	0.00351	CcSEcCtD
Perflutren—Convulsion—Vincristine—colon cancer	0.00349	0.00349	CcSEcCtD
Perflutren—Hypertension—Vincristine—colon cancer	0.00348	0.00348	CcSEcCtD
Perflutren—Loss of consciousness—Irinotecan—colon cancer	0.00345	0.00345	CcSEcCtD
Perflutren—Myalgia—Vincristine—colon cancer	0.00343	0.00343	CcSEcCtD
Perflutren—Visual disturbance—Methotrexate—colon cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Cough—Irinotecan—colon cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Hypertension—Irinotecan—colon cancer	0.00339	0.00339	CcSEcCtD
Perflutren—Leukopenia—Fluorouracil—colon cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Anaphylactoid reaction—Methotrexate—colon cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Discomfort—Irinotecan—colon cancer	0.0033	0.0033	CcSEcCtD
Perflutren—Neuropathy peripheral—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Anaphylactic shock—Vincristine—colon cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Oedema—Vincristine—colon cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Conjunctivitis—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Perflutren—Convulsion—Fluorouracil—colon cancer	0.00325	0.00325	CcSEcCtD
Perflutren—Nervous system disorder—Vincristine—colon cancer	0.00322	0.00322	CcSEcCtD
Perflutren—Anaphylactic shock—Irinotecan—colon cancer	0.0032	0.0032	CcSEcCtD
Perflutren—Oedema—Irinotecan—colon cancer	0.0032	0.0032	CcSEcCtD
Perflutren—Chest pain—Fluorouracil—colon cancer	0.0032	0.0032	CcSEcCtD
Perflutren—Myalgia—Fluorouracil—colon cancer	0.0032	0.0032	CcSEcCtD
Perflutren—Hyperhidrosis—Vincristine—colon cancer	0.00318	0.00318	CcSEcCtD
Perflutren—Discomfort—Fluorouracil—colon cancer	0.00316	0.00316	CcSEcCtD
Perflutren—Shock—Irinotecan—colon cancer	0.00315	0.00315	CcSEcCtD
Perflutren—Nervous system disorder—Irinotecan—colon cancer	0.00314	0.00314	CcSEcCtD
Perflutren—Hyperhidrosis—Irinotecan—colon cancer	0.00309	0.00309	CcSEcCtD
Perflutren—Hypotension—Vincristine—colon cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Bradycardia—Capecitabine—colon cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Oedema—Fluorouracil—colon cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Anaphylactic shock—Fluorouracil—colon cancer	0.00307	0.00307	CcSEcCtD
Perflutren—Haemoglobin—Capecitabine—colon cancer	0.00303	0.00303	CcSEcCtD
Perflutren—Rhinitis—Capecitabine—colon cancer	0.00302	0.00302	CcSEcCtD
Perflutren—Haemorrhage—Capecitabine—colon cancer	0.00302	0.00302	CcSEcCtD
Perflutren—Nervous system disorder—Fluorouracil—colon cancer	0.00301	0.00301	CcSEcCtD
Perflutren—Hypoaesthesia—Capecitabine—colon cancer	0.003	0.003	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Vincristine—colon cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Pharyngitis—Capecitabine—colon cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Tachycardia—Fluorouracil—colon cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Hypotension—Irinotecan—colon cancer	0.00299	0.00299	CcSEcCtD
Perflutren—Connective tissue disorder—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Perflutren—Paraesthesia—Vincristine—colon cancer	0.00295	0.00295	CcSEcCtD
Perflutren—Visual impairment—Capecitabine—colon cancer	0.00291	0.00291	CcSEcCtD
Perflutren—Paraesthesia—Irinotecan—colon cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Hypotension—Fluorouracil—colon cancer	0.00286	0.00286	CcSEcCtD
Perflutren—Dyspnoea—Irinotecan—colon cancer	0.00285	0.00285	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vincristine—colon cancer	0.00284	0.00284	CcSEcCtD
Perflutren—Fatigue—Vincristine—colon cancer	0.00283	0.00283	CcSEcCtD
Perflutren—Eye disorder—Capecitabine—colon cancer	0.00282	0.00282	CcSEcCtD
Perflutren—Dyspepsia—Irinotecan—colon cancer	0.00282	0.00282	CcSEcCtD
Perflutren—Tinnitus—Capecitabine—colon cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Pain—Vincristine—colon cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Cardiac disorder—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Perflutren—Flushing—Capecitabine—colon cancer	0.0028	0.0028	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00279	0.00279	CcSEcCtD
Perflutren—Eosinophilia—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Perflutren—Gastrointestinal disorder—Irinotecan—colon cancer	0.00276	0.00276	CcSEcCtD
Perflutren—Fatigue—Irinotecan—colon cancer	0.00276	0.00276	CcSEcCtD
Perflutren—Paraesthesia—Fluorouracil—colon cancer	0.00275	0.00275	CcSEcCtD
Perflutren—Pain—Irinotecan—colon cancer	0.00274	0.00274	CcSEcCtD
Perflutren—Angiopathy—Capecitabine—colon cancer	0.00274	0.00274	CcSEcCtD
Perflutren—Dyspnoea—Fluorouracil—colon cancer	0.00273	0.00273	CcSEcCtD
Perflutren—Immune system disorder—Capecitabine—colon cancer	0.00272	0.00272	CcSEcCtD
Perflutren—Mediastinal disorder—Capecitabine—colon cancer	0.00272	0.00272	CcSEcCtD
Perflutren—Chills—Capecitabine—colon cancer	0.00271	0.00271	CcSEcCtD
Perflutren—Dyspepsia—Fluorouracil—colon cancer	0.0027	0.0027	CcSEcCtD
Perflutren—Arrhythmia—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Perflutren—Gastrointestinal pain—Vincristine—colon cancer	0.00269	0.00269	CcSEcCtD
Perflutren—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00265	0.00265	CcSEcCtD
Perflutren—Feeling abnormal—Irinotecan—colon cancer	0.00264	0.00264	CcSEcCtD
Perflutren—Erythema—Capecitabine—colon cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Pain—Fluorouracil—colon cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Gastrointestinal pain—Irinotecan—colon cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Body temperature increased—Vincristine—colon cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Abdominal pain—Vincristine—colon cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Dysgeusia—Capecitabine—colon cancer	0.00257	0.00257	CcSEcCtD
Perflutren—Back pain—Capecitabine—colon cancer	0.00254	0.00254	CcSEcCtD
Perflutren—Abdominal pain—Irinotecan—colon cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Body temperature increased—Irinotecan—colon cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Feeling abnormal—Fluorouracil—colon cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Muscle spasms—Capecitabine—colon cancer	0.00252	0.00252	CcSEcCtD
Perflutren—Vision blurred—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Perflutren—Tremor—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Perflutren—Ill-defined disorder—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Perflutren—Urticaria—Fluorouracil—colon cancer	0.00244	0.00244	CcSEcCtD
Perflutren—Conjunctivitis—Methotrexate—colon cancer	0.00243	0.00243	CcSEcCtD
Perflutren—Body temperature increased—Fluorouracil—colon cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Hypersensitivity—Vincristine—colon cancer	0.00242	0.00242	CcSEcCtD
Perflutren—Malaise—Capecitabine—colon cancer	0.00237	0.00237	CcSEcCtD
Perflutren—Vertigo—Capecitabine—colon cancer	0.00236	0.00236	CcSEcCtD
Perflutren—Hypersensitivity—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Perflutren—Asthenia—Vincristine—colon cancer	0.00236	0.00236	CcSEcCtD
Perflutren—Syncope—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Perflutren—Leukopenia—Capecitabine—colon cancer	0.00235	0.00235	CcSEcCtD
Perflutren—Palpitations—Capecitabine—colon cancer	0.00232	0.00232	CcSEcCtD
Perflutren—Loss of consciousness—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Perflutren—Asthenia—Irinotecan—colon cancer	0.0023	0.0023	CcSEcCtD
Perflutren—Cough—Capecitabine—colon cancer	0.00229	0.00229	CcSEcCtD
Perflutren—Hypertension—Capecitabine—colon cancer	0.00227	0.00227	CcSEcCtD
Perflutren—Hypersensitivity—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Haemoglobin—Methotrexate—colon cancer	0.00226	0.00226	CcSEcCtD
Perflutren—Diarrhoea—Vincristine—colon cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Haemorrhage—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Perflutren—Arthralgia—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Perflutren—Chest pain—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Perflutren—Myalgia—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Perflutren—Pharyngitis—Methotrexate—colon cancer	0.00223	0.00223	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00222	0.00222	CcSEcCtD
Perflutren—Discomfort—Capecitabine—colon cancer	0.00221	0.00221	CcSEcCtD
Perflutren—Diarrhoea—Irinotecan—colon cancer	0.00219	0.00219	CcSEcCtD
Perflutren—Dry mouth—Capecitabine—colon cancer	0.00219	0.00219	CcSEcCtD
Perflutren—Dizziness—Vincristine—colon cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Pruritus—Fluorouracil—colon cancer	0.00217	0.00217	CcSEcCtD
Perflutren—Visual impairment—Methotrexate—colon cancer	0.00216	0.00216	CcSEcCtD
Perflutren—Oedema—Capecitabine—colon cancer	0.00214	0.00214	CcSEcCtD
Perflutren—Dizziness—Irinotecan—colon cancer	0.00212	0.00212	CcSEcCtD
Perflutren—Shock—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Perflutren—Nervous system disorder—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Eye disorder—Methotrexate—colon cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Diarrhoea—Fluorouracil—colon cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Tinnitus—Methotrexate—colon cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Tachycardia—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Vomiting—Vincristine—colon cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Cardiac disorder—Methotrexate—colon cancer	0.00208	0.00208	CcSEcCtD
Perflutren—Skin disorder—Capecitabine—colon cancer	0.00208	0.00208	CcSEcCtD
Perflutren—Rash—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Hyperhidrosis—Capecitabine—colon cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Dermatitis—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Perflutren—Headache—Vincristine—colon cancer	0.00206	0.00206	CcSEcCtD
Perflutren—Angiopathy—Methotrexate—colon cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Vomiting—Irinotecan—colon cancer	0.00204	0.00204	CcSEcCtD
Perflutren—Immune system disorder—Methotrexate—colon cancer	0.00203	0.00203	CcSEcCtD
Perflutren—Dizziness—Fluorouracil—colon cancer	0.00203	0.00203	CcSEcCtD
Perflutren—Mediastinal disorder—Methotrexate—colon cancer	0.00202	0.00202	CcSEcCtD
Perflutren—Rash—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Perflutren—Dermatitis—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Perflutren—Chills—Methotrexate—colon cancer	0.00201	0.00201	CcSEcCtD
Perflutren—Headache—Irinotecan—colon cancer	0.00201	0.00201	CcSEcCtD
Perflutren—Hypotension—Capecitabine—colon cancer	0.002	0.002	CcSEcCtD
Perflutren—Erythema—Methotrexate—colon cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Nausea—Vincristine—colon cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Vomiting—Fluorouracil—colon cancer	0.00195	0.00195	CcSEcCtD
Perflutren—Rash—Fluorouracil—colon cancer	0.00193	0.00193	CcSEcCtD
Perflutren—Dermatitis—Fluorouracil—colon cancer	0.00193	0.00193	CcSEcCtD
Perflutren—Paraesthesia—Capecitabine—colon cancer	0.00192	0.00192	CcSEcCtD
Perflutren—Headache—Fluorouracil—colon cancer	0.00192	0.00192	CcSEcCtD
Perflutren—Dysgeusia—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Perflutren—Dyspnoea—Capecitabine—colon cancer	0.00191	0.00191	CcSEcCtD
Perflutren—Nausea—Irinotecan—colon cancer	0.0019	0.0019	CcSEcCtD
Perflutren—Back pain—Methotrexate—colon cancer	0.00189	0.00189	CcSEcCtD
Perflutren—Dyspepsia—Capecitabine—colon cancer	0.00189	0.00189	CcSEcCtD
Perflutren—Gastrointestinal disorder—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Perflutren—Fatigue—Capecitabine—colon cancer	0.00185	0.00185	CcSEcCtD
Perflutren—Vision blurred—Methotrexate—colon cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Pain—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Perflutren—Nausea—Fluorouracil—colon cancer	0.00182	0.00182	CcSEcCtD
Perflutren—Ill-defined disorder—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Perflutren—Feeling abnormal—Capecitabine—colon cancer	0.00177	0.00177	CcSEcCtD
Perflutren—Malaise—Methotrexate—colon cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Vertigo—Methotrexate—colon cancer	0.00176	0.00176	CcSEcCtD
Perflutren—Gastrointestinal pain—Capecitabine—colon cancer	0.00175	0.00175	CcSEcCtD
Perflutren—Leukopenia—Methotrexate—colon cancer	0.00175	0.00175	CcSEcCtD
Perflutren—Cough—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Urticaria—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Abdominal pain—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Body temperature increased—Capecitabine—colon cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Convulsion—Methotrexate—colon cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Myalgia—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Chest pain—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Arthralgia—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00165	0.00165	CcSEcCtD
Perflutren—Discomfort—Methotrexate—colon cancer	0.00164	0.00164	CcSEcCtD
Perflutren—Anaphylactic shock—Methotrexate—colon cancer	0.00159	0.00159	CcSEcCtD
Perflutren—Hypersensitivity—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Perflutren—Nervous system disorder—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Perflutren—Skin disorder—Methotrexate—colon cancer	0.00155	0.00155	CcSEcCtD
Perflutren—Hyperhidrosis—Methotrexate—colon cancer	0.00154	0.00154	CcSEcCtD
Perflutren—Asthenia—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Perflutren—Pruritus—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Perflutren—Hypotension—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Perflutren—Diarrhoea—Capecitabine—colon cancer	0.00147	0.00147	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Perflutren—Paraesthesia—Methotrexate—colon cancer	0.00143	0.00143	CcSEcCtD
Perflutren—Dyspnoea—Methotrexate—colon cancer	0.00142	0.00142	CcSEcCtD
Perflutren—Dizziness—Capecitabine—colon cancer	0.00142	0.00142	CcSEcCtD
Perflutren—Dyspepsia—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Perflutren—Gastrointestinal disorder—Methotrexate—colon cancer	0.00138	0.00138	CcSEcCtD
Perflutren—Fatigue—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Perflutren—Pain—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Vomiting—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Rash—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Perflutren—Dermatitis—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Perflutren—Headache—Capecitabine—colon cancer	0.00134	0.00134	CcSEcCtD
Perflutren—Feeling abnormal—Methotrexate—colon cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Gastrointestinal pain—Methotrexate—colon cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Nausea—Capecitabine—colon cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Urticaria—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Abdominal pain—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Body temperature increased—Methotrexate—colon cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Hypersensitivity—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Asthenia—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Perflutren—Pruritus—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Diarrhoea—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Perflutren—Dizziness—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Perflutren—Vomiting—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Rash—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Perflutren—Dermatitis—Methotrexate—colon cancer	0.001	0.001	CcSEcCtD
Perflutren—Headache—Methotrexate—colon cancer	0.000999	0.000999	CcSEcCtD
Perflutren—Nausea—Methotrexate—colon cancer	0.000947	0.000947	CcSEcCtD
